Watch Ticker

Alumis Inc. Common Stock

Go to Alumis Inc. Common Stock Website

$4.37

0.00 (0.00%)

Live

Previous Close

$4.37

Day Range

$0 - $0

Previous Day Range

$4.1515 - $4.39

Market Cap

$433.4 million USD

Day Vol.

Previous Day Vol.

480739

Currency

USD

Primary Exchange

None

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision d...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Globe Newswire - Alumis Completes Merger with ACELYRIN

Alumis Inc. has completed its merger with ACELYRIN, Inc. The merger strengthens Alumis' balance sheet and supports the advancement of its late-stage pipeline of targeted therapies for immune-mediated diseases.

Related tickers: ALMS, SLRN.

Read Full Article

N/A - Alumis Stockholders Approve Merger with ACELYRIN

Alumis Inc. and ACELYRIN, INC. announced that Alumis' stockholders voted to approve the pending merger between the two companies. The merger is expected to close in the second quarter of 2025, subject to customary closing conditions.

Related tickers: ALMS, SLRN.

Read Full Article

Trending Tickers

Please sign in to view